Clinical trials of medications are a fairly arcane world with huge complexity, compliance requirement and cost. So it is interesting to see a platform launch that aims to change that — as much as is possible within the constraints.
ProofPilot is an online platform for designing, launching and managing longitudinal trials and research studies. The company isn’t exactly new — to be honest, it was actually founded back in 2003. But the wheels of progress within this industry turn slowly, and ProofPilot has been quietly building both product and customer base.
ProofPilot, since it was first launched into the wild, has been used by organizations and institutions such as Johns Hopkins, The Huffington Post, the Centers for Disease Control and Prevention (CDC), NYC Health, AIDS Clinical Trials Group (ACTG), UConn, UCSF School of Medicine, Georgia State University and Southwestern Medical Center. In that time, it has enabled its users to launch studies two times faster and for a third of the operational cost.
To read this article in full or to leave a comment, please click here
